Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03307005 · ClinicalTrials.gov registry record · Phase 4
Improving Sleep Quality in Heart Failure
A Phase 4 study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- Phase 4
- Development phase
- 5
- Enrollment target
NCT03307005: Completed Phase 4 study, sponsored by Johns Hopkins University.
NCT03307005 is a Phase 4 study that has completed, run by Johns Hopkins University. The registered enrollment target is 5 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03307005, a Phase 4 study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 5 participants
- Enrollment target
Study Summary
Poor sleep quality is common in patients with heart failure. The limited available evidence intimates that improving sleep quality in patients with heart failure may improve morbidity and quality of life in this patient population. However, there is a paucity of evidence assessing the use of effective pharmacologic therapies in heart failure. The nonbenzodiazepine, GABA receptor agonist, zolpidem, has been found to have considerable benefits over traditional benzodiazepines as a soporific medication. The investigators hypothesize that zolpidem will safely improve sleep quality in patients with heart failure.
Interventions
- DRUG Placebo oral capsule
- DRUG Zolpidem Tartrate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2017-11-01 |
| Est. Completion | 2019-01-25 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03307005
The ClinicalTrials.gov registry entry for NCT03307005 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo oral capsule is the first listed.
NCT03307005 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03307005 about?
NCT03307005 is a clinical study titled "Improving Sleep Quality in Heart Failure". Poor sleep quality is common in patients with heart failure. The limited available evidence intimates that improving sleep quality in patients with heart failure may improve morbidity and quality of life in this patient population. However, there is a paucity of evidence assessing the use of effecti...
What is the current status of trial NCT03307005?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 5 participants. The study started on 2017-11-01. Estimated completion is 2019-01-25.
What interventions are being tested in trial NCT03307005?
The interventions under investigation include: Placebo oral capsule (DRUG), Zolpidem Tartrate (DRUG).
Who is sponsoring clinical trial NCT03307005?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.